Tag: tolebrutinib
From tolebrutinib to the Zantac affair, Sanofi loses 20 billion in market capitalization in three sessions
For analysts from Oddo BHF, it is ” a start of the week to forget as soon as possible “. What could be more obvious, observing Sanofi’s plunge of more…
Sanofi backs down, recruitment of tolebrutinib trials suspended
Sanofi backs down, recruitment of tolebrutinib trials suspended | Photo credits: Sanofi Pasteur/Randy Monceaux PARIS, Aug 9 (Reuters) – Sanofi fell on the stock market on Tuesday morning after announcing…
Sanofi weighed down by new delays for its drug tolebrutinib and a note from UBS
If the market is very cautious on Tuesday, on the eve of crucial inflation figures in the United States for the month of July, it is even more so on…
Sanofi backs down, recruitment of tolebrutinib trials suspended
PARIS (Reuters) – Sanofi fell on the stock market on Tuesday morning after the announcement of the cessation of recruitment for clinical trials of tolbrutinib, an experimental treatment for certain…